Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Chapman

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|March 24, 2025
COPD Exacerbations, Air Pollutant Fluctuations, and Individual-Level Factors in the Pandemic EraSahar Mikaeeli, Dany Doiron, Jean Bourbeau, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 19, 2021
The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) StudyClarus Leung, Jean Bourbeau, Don D Sin, et al.
The Lancet. Respiratory Medicine|September 13, 2016
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsNicola A Hanania, Phillip Korenblat, Kenneth R Chapman, et al.
Chest|June 1, 2019
Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort StudyMatthew Shorofsky, Jean Bourbeau, John Kimoff, et al.
The European Respiratory Journal|September 14, 2017
Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD studyRiany de Sousa Sena, Sara Ahmed, Wan C Tan, et al.
Chest|July 22, 2020
Triaging Access to Critical Care Resources in Patients With Chronic Respiratory Diseases in the Event of a Major COVID-19 Surge: Key Highlights From the Canadian Thoracic Society (CTS) Position StatementSamir Gupta, Jane Batt, Jean Bourbeau, et al.
The European Respiratory Journal|September 21, 2019
The effects of marijuana smoking on lung function in older peopleWan C Tan, Jean Bourbeau, Shawn D Aaron, et al.
ERJ Open Research|July 1, 2025
Utility of diaphragm dome height as a marker of operational lung volume changes, disease burden and exacerbations in patients with mild-to-moderate COPD: an observational study within the CanCOLD cohortSarah A Beydoun, Olivia C Iorio, Daniel Genkin, et al.
ERJ Open Research|April 26, 2021
Dyspnoea and symptom burden in mild-moderate COPD: the Canadian Cohort Obstructive Lung Disease StudyMathew Cherian, Dennis Jensen, Wan C Tan, et al.
Respirology (Carlton, Vic.)|February 18, 2020
Identification and definition of asthma-COPD overlap: The CanCOLD studyMiriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Chronic Obstructive Pulmonary Disease|March 24, 2025
COPD Exacerbations, Air Pollutant Fluctuations, and Individual-Level Factors in the Pandemic EraSahar Mikaeeli, Dany Doiron, Jean Bourbeau, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 19, 2021
The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) StudyClarus Leung, Jean Bourbeau, Don D Sin, et al.
The Lancet. Respiratory Medicine|September 13, 2016
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsNicola A Hanania, Phillip Korenblat, Kenneth R Chapman, et al.
Chest|June 1, 2019
Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort StudyMatthew Shorofsky, Jean Bourbeau, John Kimoff, et al.
The European Respiratory Journal|September 14, 2017
Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD studyRiany de Sousa Sena, Sara Ahmed, Wan C Tan, et al.
Chest|July 22, 2020
Triaging Access to Critical Care Resources in Patients With Chronic Respiratory Diseases in the Event of a Major COVID-19 Surge: Key Highlights From the Canadian Thoracic Society (CTS) Position StatementSamir Gupta, Jane Batt, Jean Bourbeau, et al.
The European Respiratory Journal|September 21, 2019
The effects of marijuana smoking on lung function in older peopleWan C Tan, Jean Bourbeau, Shawn D Aaron, et al.
ERJ Open Research|July 1, 2025
Utility of diaphragm dome height as a marker of operational lung volume changes, disease burden and exacerbations in patients with mild-to-moderate COPD: an observational study within the CanCOLD cohortSarah A Beydoun, Olivia C Iorio, Daniel Genkin, et al.
ERJ Open Research|April 26, 2021
Dyspnoea and symptom burden in mild-moderate COPD: the Canadian Cohort Obstructive Lung Disease StudyMathew Cherian, Dennis Jensen, Wan C Tan, et al.
Respirology (Carlton, Vic.)|February 18, 2020
Identification and definition of asthma-COPD overlap: The CanCOLD studyMiriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, et al.
Pageof 18